Your browser doesn't support javascript.
loading
Low-dose rituximab treatment for new-onset generalized myasthenia gravis.
Li, Huining; Huang, Zhenning; Jia, Dongmei; Xue, Huiru; Pan, Jing; Zhang, Meini; Shi, Kaibin; Shi, Fu-Dong; Zhang, Chao.
Afiliação
  • Li H; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Huang Z; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Jia D; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Xue H; Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Pan J; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Zhang M; Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Shi K; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Shi FD; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Zhang C; Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China. Electronic address: chaozhang@tmu.edu.cn.
J Neuroimmunol ; 354: 577528, 2021 05 15.
Article em En | MEDLINE | ID: mdl-33662696

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Rituximab / Fatores Imunológicos / Miastenia Gravis Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Rituximab / Fatores Imunológicos / Miastenia Gravis Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article